Regulatory actions for July 30, 2026Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Allogene, Amgen, Eton, Hopstem, Incyte, Insilico, Neuropace, Ocugen, Perspective, Polypid, Sandoz, Viatris, Voxneuro.